Μονοκλωνικό αντίσωμα (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Μονοκλωνικό αντίσωμα" in Greek language version.

refsWebsite

Global rank Greek rank

4^th place

4^th place

2^nd place

3^rd place

18^th place

57^th place

6^th place

5^th place

1,684^th place

784^th place

2,814^th place

6,489^th place

1whatisbiotechnology.org

low place

low place

1landesbioscience.com

low place

low place

14^th place

37^th place

670^th place

807^th place

2,393^rd place

1,822^nd place

1australianprescriber.com

low place

low place

1cancernetwork.com

low place

low place

1web.archive.org

1^st place

1^st place

3,680^th place

2,849^th place

1mayoclinic.org

1,610^th place

485^th place

1medicinenet.com

3,840^th place

1,331^st place

archive.org

«Mature B cells class switched to IgD are autoreactive in healthy individuals». The Journal of Clinical Investigation 117 (6): 1558–65. June 2007. doi:10.1172/JCI27628. PMID 17510706. PMC 1866247. https://archive.org/details/sim_journal-of-clinical-investigation_2007-06_117_6/page/1558.
«Quality by design for biopharmaceuticals». Nature Biotechnology 27 (1): 26–34. January 2009. doi:10.1038/nbt0109-26. PMID 19131992. https://archive.org/details/sim_nature-biotechnology_2009-01_27_1/page/26.
Pharmacology. Edinburgh: Churchill Livingstone. 2003. σελίδες 241, for the examples infliximab, basiliximab, abciximab, daclizumab, palivusamab, gemtuzumab, alemtuzumab and rituximab, and mechanism and mode. ISBN 978-0-443-07145-4.

archive.today

«Dr. George Pieczenik». LMB Alumni. MRC Laboratory of Molecular Biology (LMB). 17 Σεπτεμβρίου 2009. Αρχειοθετήθηκε από το πρωτότυπο στις 23 Δεκεμβρίου 2012. Ανακτήθηκε στις 17 Νοεμβρίου 2012.

australianprescriber.com

Australian Prescriber (2006). «Monoclonal antibody therapy for non-malignant disease». Australian Prescriber 29 (5): 130–133. doi:10.18773/austprescr.2006.079. http://www.australianprescriber.com/magazine/29/5/130/3/#2.

cam.ac.uk

www2.mrc-lmb.cam.ac.uk

«Dr. George Pieczenik». LMB Alumni. MRC Laboratory of Molecular Biology (LMB). 17 Σεπτεμβρίου 2009. Αρχειοθετήθηκε από το πρωτότυπο στις 23 Δεκεμβρίου 2012. Ανακτήθηκε στις 17 Νοεμβρίου 2012.

cancer.gov

home.ccr.cancer.gov

«Cytochrome P450 Mediated Drug and Carcinogen Metabolism using Monoclonal Antibodies». home.ccr.cancer.gov. Ανακτήθηκε στις 2 Απριλίου 2018.

cancer.org

«Monoclonal antibodies to treat cancer | American Cancer Society». www.cancer.org. Ανακτήθηκε στις 19 Απριλίου 2018.

cancernetwork.com

Takimoto CH, Calvo E. (January 01, 2005) "Principles of Oncologic Pharmacotherapy" Αρχειοθετήθηκε 2017-07-22 στο Wayback Machine. in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer Management Αρχειοθετήθηκε 2013-10-04 στο Wayback Machine.

cell.com

«Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery». Trends in Pharmacological Sciences 20 (11): 432–8. November 1999. doi:10.1016/S0165-6147(99)01382-6. PMID 10542439. http://www.cell.com/trends/pharmacological-sciences/comments/S0165-6147(99)01382-6.

doi.org

dx.doi.org

«Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery». Trends in Pharmacological Sciences 20 (11): 432–8. November 1999. doi:10.1016/S0165-6147(99)01382-6. PMID 10542439. http://www.cell.com/trends/pharmacological-sciences/comments/S0165-6147(99)01382-6.
«Monoclonal antibodies: a witness seminar in contemporary medical history». Medical History 38 (3): 322–7. July 1994. doi:10.1017/s0025727300036632. PMID 7934322.
«Human x mouse somatic cell hybrid clone secreting immunoglobulins of both parental types». Nature 244 (5416): 444–7. August 1973. doi:10.1038/244444a0. PMID 4200460.
«Between fact and technique: the beginnings of hybridoma technology». Journal of the History of Biology 25 (2): 175–230. 1992. doi:10.1007/BF00162840. PMID 11623041.
«Reshaping human antibodies for therapy». Nature 332 (6162): 323–7. March 1988. doi:10.1038/332323a0. PMID 3127726. Bibcode: 1988Natur.332..323R.
«A Nobel Prize-worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens». Immunology 155 (3): 283–284. November 2018. doi:10.1111/imm.13008. PMID 30320408.
«Inaugural Editorial: Searching for Magic Bullets». Antibody Therapeutics 1 (1): 1–5. June 2018. doi:10.1093/abt/tby001. PMID 30101214.
«A novel high-affinity human monoclonal antibody to mesothelin». International Journal of Cancer 128 (9): 2020–30. May 2011. doi:10.1002/ijc.25557. PMID 20635390.
«A robust high throughput platform to generate functional recombinant monoclonal antibodies using rabbit B cells from peripheral blood». PLOS ONE 9 (2): e86184. 2014. doi:10.1371/journal.pone.0086184. PMID 24503933. Bibcode: 2014PLoSO...986184S.
«Predominant autoantibody production by early human B cell precursors». Science 301 (5638): 1374–7. September 2003. doi:10.1126/science.1086907. PMID 12920303. Bibcode: 2003Sci...301.1374W.
«Mature B cells class switched to IgD are autoreactive in healthy individuals». The Journal of Clinical Investigation 117 (6): 1558–65. June 2007. doi:10.1172/JCI27628. PMID 17510706. PMC 1866247. https://archive.org/details/sim_journal-of-clinical-investigation_2007-06_117_6/page/1558.
«Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen». Nature Protocols 4 (3): 372–84. 2009-01-01. doi:10.1038/nprot.2009.3. PMID 19247287.
«Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors». The Journal of Experimental Medicine 206 (1): 139–51. January 2009. doi:10.1084/jem.20080611. PMID 19103878.
«Isolation of human monoclonal antibodies from peripheral blood B cells». Nature Protocols 8 (10): 1907–15. October 2013. doi:10.1038/nprot.2013.117. PMID 24030440.
«Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods». Current Pharmaceutical Biotechnology 9 (6): 468–81. December 2008. doi:10.2174/138920108786786402. PMID 19075686.
«Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats». mAbs 2 (6): 613–24. 2010. doi:10.4161/mabs.2.6.13333. PMID 20818176. PMC 3011216. http://www.landesbioscience.com/journals/mabs/abstract.php?id=13333.
«Isolation and characterization of therapeutic antibody charge variants using cation exchange displacement chromatography». Journal of Chromatography A 1218 (31): 5079–86. August 2011. doi:10.1016/j.chroma.2011.05.061. PMID 21700290.
«Quality by design for biopharmaceuticals». Nature Biotechnology 27 (1): 26–34. January 2009. doi:10.1038/nbt0109-26. PMID 19131992. https://archive.org/details/sim_nature-biotechnology_2009-01_27_1/page/26.
«Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering». Science Advances 5 (8): eaaw1822. August 2019. doi:10.1126/sciadv.aaw1822. PMID 31489367.
«Recombinant monoclonal antibody technology». Transfusion Clinique et Biologique 9 (1): 15–22. January 2002. doi:10.1016/S1246-7820(01)00210-5. PMID 11889896.
«Phage display: a molecular tool for the generation of antibodies--a review». Placenta 21 Suppl A (Suppl A): S106-12. 2000. doi:10.1053/plac.1999.0511. PMID 10831134.
«Production of functional chimaeric mouse/human antibody». Nature 312 (5995): 643–6. 1984. doi:10.1038/312643a0. PMID 6095115.
«Therapeutic antibody expression technology». Current Opinion in Biotechnology 12 (2): 188–94. April 2001. doi:10.1016/S0958-1669(00)00198-1. PMID 11287236.
«Human antibodies from transgenic mice». International Reviews of Immunology 13 (1): 65–93. 1995. doi:10.3109/08830189509061738. PMID 7494109.
«Therapeutic monoclonal antibodies». Lancet 355 (9205): 735–40. February 2000. doi:10.1016/S0140-6736(00)01034-5. PMID 10703815. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(00)01034-5/fulltext.
Australian Prescriber (2006). «Monoclonal antibody therapy for non-malignant disease». Australian Prescriber 29 (5): 130–133. doi:10.18773/austprescr.2006.079. http://www.australianprescriber.com/magazine/29/5/130/3/#2.

harvard.edu

adsabs.harvard.edu

«Reshaping human antibodies for therapy». Nature 332 (6162): 323–7. March 1988. doi:10.1038/332323a0. PMID 3127726. Bibcode: 1988Natur.332..323R.
«A robust high throughput platform to generate functional recombinant monoclonal antibodies using rabbit B cells from peripheral blood». PLOS ONE 9 (2): e86184. 2014. doi:10.1371/journal.pone.0086184. PMID 24503933. Bibcode: 2014PLoSO...986184S.
«Predominant autoantibody production by early human B cell precursors». Science 301 (5638): 1374–7. September 2003. doi:10.1126/science.1086907. PMID 12920303. Bibcode: 2003Sci...301.1374W.

landesbioscience.com

«Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats». mAbs 2 (6): 613–24. 2010. doi:10.4161/mabs.2.6.13333. PMID 20818176. PMC 3011216. http://www.landesbioscience.com/journals/mabs/abstract.php?id=13333.

mayoclinic.org

«Monoclonal antibody drugs for cancer: How they work». Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/cancer/in-depth/monoclonal-antibody/art-20047808. Ανακτήθηκε στις 2018-04-19.

medicinenet.com

«Monoclonal Antibodies: List, Types, Side Effects & FDA Uses (Cancer)». MedicineNet. https://www.medicinenet.com/monoclonal_antibodies/article.htm#what_drugs_or_other_compounds_interact_with_monoclonal_antibodies?. Ανακτήθηκε στις 2018-04-19.

nih.gov

ncbi.nlm.nih.gov

«Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery». Trends in Pharmacological Sciences 20 (11): 432–8. November 1999. doi:10.1016/S0165-6147(99)01382-6. PMID 10542439. http://www.cell.com/trends/pharmacological-sciences/comments/S0165-6147(99)01382-6.
«Monoclonal antibodies: a witness seminar in contemporary medical history». Medical History 38 (3): 322–7. July 1994. doi:10.1017/s0025727300036632. PMID 7934322.
«Human x mouse somatic cell hybrid clone secreting immunoglobulins of both parental types». Nature 244 (5416): 444–7. August 1973. doi:10.1038/244444a0. PMID 4200460.
«Between fact and technique: the beginnings of hybridoma technology». Journal of the History of Biology 25 (2): 175–230. 1992. doi:10.1007/BF00162840. PMID 11623041.
«Reshaping human antibodies for therapy». Nature 332 (6162): 323–7. March 1988. doi:10.1038/332323a0. PMID 3127726. Bibcode: 1988Natur.332..323R.
«A Nobel Prize-worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens». Immunology 155 (3): 283–284. November 2018. doi:10.1111/imm.13008. PMID 30320408.
National Research Council (US) Committee on Methods of Producing Monoclonal Antibodies. Recommendation 1: Executive Summary: Monoclonal Antibody Production. Washington (DC): National Academies Press (US); 1999. (ISBN 978-0-309-07511-4)
«Inaugural Editorial: Searching for Magic Bullets». Antibody Therapeutics 1 (1): 1–5. June 2018. doi:10.1093/abt/tby001. PMID 30101214.
«A novel high-affinity human monoclonal antibody to mesothelin». International Journal of Cancer 128 (9): 2020–30. May 2011. doi:10.1002/ijc.25557. PMID 20635390.
«A robust high throughput platform to generate functional recombinant monoclonal antibodies using rabbit B cells from peripheral blood». PLOS ONE 9 (2): e86184. 2014. doi:10.1371/journal.pone.0086184. PMID 24503933. Bibcode: 2014PLoSO...986184S.
«Predominant autoantibody production by early human B cell precursors». Science 301 (5638): 1374–7. September 2003. doi:10.1126/science.1086907. PMID 12920303. Bibcode: 2003Sci...301.1374W.
«Mature B cells class switched to IgD are autoreactive in healthy individuals». The Journal of Clinical Investigation 117 (6): 1558–65. June 2007. doi:10.1172/JCI27628. PMID 17510706. PMC 1866247. https://archive.org/details/sim_journal-of-clinical-investigation_2007-06_117_6/page/1558.
«Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen». Nature Protocols 4 (3): 372–84. 2009-01-01. doi:10.1038/nprot.2009.3. PMID 19247287.
«Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors». The Journal of Experimental Medicine 206 (1): 139–51. January 2009. doi:10.1084/jem.20080611. PMID 19103878.
«Isolation of human monoclonal antibodies from peripheral blood B cells». Nature Protocols 8 (10): 1907–15. October 2013. doi:10.1038/nprot.2013.117. PMID 24030440.
«Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods». Current Pharmaceutical Biotechnology 9 (6): 468–81. December 2008. doi:10.2174/138920108786786402. PMID 19075686.
«Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats». mAbs 2 (6): 613–24. 2010. doi:10.4161/mabs.2.6.13333. PMID 20818176. PMC 3011216. http://www.landesbioscience.com/journals/mabs/abstract.php?id=13333.
«Isolation and characterization of therapeutic antibody charge variants using cation exchange displacement chromatography». Journal of Chromatography A 1218 (31): 5079–86. August 2011. doi:10.1016/j.chroma.2011.05.061. PMID 21700290.
«Quality by design for biopharmaceuticals». Nature Biotechnology 27 (1): 26–34. January 2009. doi:10.1038/nbt0109-26. PMID 19131992. https://archive.org/details/sim_nature-biotechnology_2009-01_27_1/page/26.
«Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering». Science Advances 5 (8): eaaw1822. August 2019. doi:10.1126/sciadv.aaw1822. PMID 31489367.
«Recombinant monoclonal antibody technology». Transfusion Clinique et Biologique 9 (1): 15–22. January 2002. doi:10.1016/S1246-7820(01)00210-5. PMID 11889896.
«Phage display: a molecular tool for the generation of antibodies--a review». Placenta 21 Suppl A (Suppl A): S106-12. 2000. doi:10.1053/plac.1999.0511. PMID 10831134.
«Production of functional chimaeric mouse/human antibody». Nature 312 (5995): 643–6. 1984. doi:10.1038/312643a0. PMID 6095115.
«Therapeutic antibody expression technology». Current Opinion in Biotechnology 12 (2): 188–94. April 2001. doi:10.1016/S0958-1669(00)00198-1. PMID 11287236.
«Human antibodies from transgenic mice». International Reviews of Immunology 13 (1): 65–93. 1995. doi:10.3109/08830189509061738. PMID 7494109.
«Therapeutic monoclonal antibodies». Lancet 355 (9205): 735–40. February 2000. doi:10.1016/S0140-6736(00)01034-5. PMID 10703815. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(00)01034-5/fulltext.

pubmedcentral.nih.gov

«Monoclonal antibodies: a witness seminar in contemporary medical history». Medical History 38 (3): 322–7. July 1994. doi:10.1017/s0025727300036632. PMID 7934322.
«A Nobel Prize-worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens». Immunology 155 (3): 283–284. November 2018. doi:10.1111/imm.13008. PMID 30320408.
«Inaugural Editorial: Searching for Magic Bullets». Antibody Therapeutics 1 (1): 1–5. June 2018. doi:10.1093/abt/tby001. PMID 30101214.
«A novel high-affinity human monoclonal antibody to mesothelin». International Journal of Cancer 128 (9): 2020–30. May 2011. doi:10.1002/ijc.25557. PMID 20635390.
«A robust high throughput platform to generate functional recombinant monoclonal antibodies using rabbit B cells from peripheral blood». PLOS ONE 9 (2): e86184. 2014. doi:10.1371/journal.pone.0086184. PMID 24503933. Bibcode: 2014PLoSO...986184S.
«Mature B cells class switched to IgD are autoreactive in healthy individuals». The Journal of Clinical Investigation 117 (6): 1558–65. June 2007. doi:10.1172/JCI27628. PMID 17510706. PMC 1866247. https://archive.org/details/sim_journal-of-clinical-investigation_2007-06_117_6/page/1558.
«Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen». Nature Protocols 4 (3): 372–84. 2009-01-01. doi:10.1038/nprot.2009.3. PMID 19247287.
«Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors». The Journal of Experimental Medicine 206 (1): 139–51. January 2009. doi:10.1084/jem.20080611. PMID 19103878.
«Isolation of human monoclonal antibodies from peripheral blood B cells». Nature Protocols 8 (10): 1907–15. October 2013. doi:10.1038/nprot.2013.117. PMID 24030440.
«Charge variants in IgG1: Isolation, characterization, in vitro binding properties and pharmacokinetics in rats». mAbs 2 (6): 613–24. 2010. doi:10.4161/mabs.2.6.13333. PMID 20818176. PMC 3011216. http://www.landesbioscience.com/journals/mabs/abstract.php?id=13333.
«Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering». Science Advances 5 (8): eaaw1822. August 2019. doi:10.1126/sciadv.aaw1822. PMID 31489367.

thelancet.com

«Therapeutic monoclonal antibodies». Lancet 355 (9205): 735–40. February 2000. doi:10.1016/S0140-6736(00)01034-5. PMID 10703815. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(00)01034-5/fulltext.

web.archive.org

Takimoto CH, Calvo E. (January 01, 2005) "Principles of Oncologic Pharmacotherapy" Αρχειοθετήθηκε 2017-07-22 στο Wayback Machine. in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer Management Αρχειοθετήθηκε 2013-10-04 στο Wayback Machine.

whatisbiotechnology.org

Marks, LV. «The Story of César Milstein and Monoclonal Antibodies». WhatisBiotechnology.org. Ανακτήθηκε στις 23 Σεπτεμβρίου 2020.